切换至 "中华医学电子期刊资源库"

中华心脏与心律电子杂志 ›› 2022, Vol. 10 ›› Issue (03) : 141 -146. doi: 10.3877/cma.j.issn.2095-6568.2022.03.003

所属专题: 总编推荐

心血管急危重症

单中心心脏再同步治疗相关并发症分析
秦付超1, 周贤惠1, 邢强1, 李耀东1, 张疆华1, 芦颜美1, 祖克拉·吐尔洪1, 杨徐1, 汤宝鹏1,()   
  1. 1. 830054 乌鲁木齐,新疆医科大学第一附属医院心脏中心起搏电生理科 新疆心电生理与心脏重塑重点实验室
  • 收稿日期:2022-05-06 出版日期:2022-09-25
  • 通信作者: 汤宝鹏
  • 基金资助:
    新疆维吾尔自治区自然基金重点项目(2022D01D15)

Analysis of complications associated with cardiac resynchronization therapy: single-center case analysis

Fuchao Qin1, Xianhui Zhou1, Qiang Xing1, Yaodong Li1, Jianghua Zhang1, Yanmei Lu1, Zukra·Turhong1, Xu Yang1, Baopeng Tang1,()   

  1. 1. Department of Pacing and Electrophysiology, Department of Cardiac Electrophysiology and Remodeling, The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China
  • Received:2022-05-06 Published:2022-09-25
  • Corresponding author: Baopeng Tang
引用本文:

秦付超, 周贤惠, 邢强, 李耀东, 张疆华, 芦颜美, 祖克拉·吐尔洪, 杨徐, 汤宝鹏. 单中心心脏再同步治疗相关并发症分析[J/OL]. 中华心脏与心律电子杂志, 2022, 10(03): 141-146.

Fuchao Qin, Xianhui Zhou, Qiang Xing, Yaodong Li, Jianghua Zhang, Yanmei Lu, Zukra·Turhong, Xu Yang, Baopeng Tang. Analysis of complications associated with cardiac resynchronization therapy: single-center case analysis[J/OL]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2022, 10(03): 141-146.

目的

回顾性总结单中心心脏再同步治疗(CRT)相关并发症概况为临床对CRT患者的管理提供相关经验。

方法

本研究为回顾性研究,纳入2009年6月至2021年6月在新疆医科大学第一附属医院心血管内科植入CRT的心力衰竭(心衰)患者,按照植入装置类型分为心脏再同步治疗除颤器(CRT-D)组和心脏再同步治疗起搏器(CRT-P)组,分析患者术中、术后发生左心室导线植入失败、膈肌刺激、冠状静脉系统损伤等相关并发症的情况及原因。

结果

共纳入469例患者,其中男359例(359/469,76.55%),年龄(62.31±11.69)岁,术前左心室射血分数为34.76%±7.96%,术前QRS时限为(161.82±30.57)ms。左心室导线植入成功率为95.1%(446/499)。术中膈肌刺激2例(0.43%);急性左心衰竭3例(6.40%);冠状静脉夹层15例(3.19%);囊袋血肿4例(0.85%);导线脱位10例(2.13%),其中急性脱位2例(20%)、亚急性脱位4例(40%)、迟发性脱位4例(40%)。

结论

CRT术中发生相关并发症的风险较高,同时也要警惕和排除发生相关术后并发症的可能。

Objective

To retrospectively summarize the complications associated with cardiac resynchronization therapy (CRT) in a single center in order to provide relevant experience for the clinical management of CRT patients.

Methods

This study is a retrospective study. Patients with heart failure who underwent CRT implantation in the Department of Cardiovascular Medicine, The First Affiliated Hospital of Xinjiang Medical University from June 2009 to June 2021 were included. The patients were divided into cardiac resynchronization therapy defibrillator (CRT-D) and cardiac resynchronization therapy pacemaker (CRT-P) according to the type of implanted device. In the CRT-P group, the failure of left ventricular lead implantation, diaphragm muscle stimulation, coronary venous system injury and other related complications were analyzed, and the reasons for the complications were recorded.

Results

A total of 469 patients were enrolled, including 359 males (359/469, 76.55%), age (62.31±11.69) years, preoperative mean left ventricular ejection fraction was 34.76%±7.96%, preoperative mean QRS duration was (161.82±30.57) ms. The success rate of left ventricular lead implantation was 95.1% (446/499), intraoperative diaphragm stimulation in 2 cases (0.43%); acute left heart failure in 3 cases (6.40%); coronary vein dissection in 15 cases (3.19%). Hematoma occurred in 4 cases (0.85%), and lead dislocation in 10 cases (2.13%), including acute dislocation in 2 cases (20%), subacute dislocation in 4 cases (40%), and delayed dislocation in 4 cases (40%).

Conclusion

The risk of complications related to CRT is high, and at the same time, we should be alert and rule out the possibility of related postoperative complications.

表1 469例植入CRT的患者基线资料
表2 植入CRT患者左心室导线植入失败相关因素及结局对比[例(%)]
表3 植入CRT-D/CRT-P患者导线脱位相关资料比较[例(%)]
图1 单中心不同时期心脏再同步治疗植入并发症发生率情况
[1]
Sohaib SM, Finegold JA, Nijjer SS, et al. Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials[J]. JACC Heart Fail, 2015, 3(4):327-336.
[2]
Boriani G, Nesti M, Ziacchi M, et al. Cardiac resynchronization therapy: an overview on guidelines [J]. Heart Fail Clin, 2017, 13(1):117-137.
[3]
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur J Heart Fail, 2016, 18(8):891-975.
[5]
Lipar L, Srivathsan K, Scott LR. Short-term outcome of cardiac resynchronization therapy-a comparison between newly implanted and chronically right ventricle-paced patients[J]. Int J Cardiol, 2016, 219:195-199.
[6]
Linde C, Gold MR, Abraham WT, et al. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study[J]. Eur Heart J, 2013, 34(33):2592-2599.
[7]
Wang Y, Gu K, Qian Z, et al. The efficacy of left bundle branch area pacing compared with biventricular pacing in patients with heart failure: a matched case-control study[J]. J Cardiovasc Electrophysiol, 2020, 31(8):2068-2077.
[8]
Wu S, Su L, Vijayaraman P, et al. left bundle branch pacing for cardiac resynchronization therapy: nonrandomized on-treatment comparison with His bundle pacing and biventricular pacing[J]. Can J Cardiol, 2021, 37(2):319-328.
[9]
Vinther M, Risum N, Svendsen JH, et al. A randomized trial of his pacing versus biventricular pacing in symptomatic HF patients with left bundle branch block (His-Alternative)[J]. JACC Clin Electrophysiol, 2021, 7(11):1422-1432.
[10]
León AR, Abraham WT, Curtis AB, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program [J]. J Am Coll Cardiol, 2005, 46(12):2348-2356.
[1] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[2] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[3] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[6] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[7] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[8] 许杰, 李亚俊, 冯义文. SOX新辅助化疗后腹腔镜胃癌D2根治术与常规根治术治疗进展期胃癌的近期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 647-650.
[9] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[10] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[11] 刘柏隆, 周祥福. 女性尿失禁吊带手术并发症处理的经验分享[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 127-127.
[12] 嵇振岭, 陈杰, 唐健雄. 重视复杂腹壁疝手术并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 601-606.
[13] 江志鹏, 钟克力, 陈双. 复杂腹壁疝手术后腹腔高压与腹腔间室综合征的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 612-615.
[14] 王学虎, 赵渝. 复杂腹壁疝手术中血管损伤并发症的预防和处理[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 616-619.
[15] 石阳, 于剑锋, 曹可, 翟志伟, 叶春祥, 王振军, 韩加刚. 可扩张金属支架置入联合新辅助化疗治疗完全梗阻性左半结肠癌围手术期并发症分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 464-471.
阅读次数
全文


摘要